Skip to main content

Table 4 Summary of findings table

From: Short implants compared to regular dental implants after bone augmentation in the atrophic posterior mandible: umbrella review and meta-analysis of success outcomes

Outcomes

Follow-up/subgroups

Sample size* (studies)

Relative effect (95% CI)

Anticipated absolute effects**

Certainty of the evidence (GRADE)

Risk with regular dental implants and bone augmentation

Risk difference with short dental implants in native bone

Implant level

 Implant failure (before and after loading)

1 year

498 (5 RCTs)

RR 0.33 (0.15 to 0.74)

87 per 1000 implants

29 fewer per 1000 implants

Lowa,e

Difference: 58 fewer per 1000 implants (74 to 23 fewer)

3 years

328 (4 RCTs)

RR 0.68 (0.22 to 2.06)

53 per 1000 implants

36 per 1000 implants

Very lowa,d,e

Difference: 17 fewer per 1000 implants (42 fewer to 56 more)

5 years

425 (4 RCTs, 1 NRSI)

RR 1.18 (0.50 to 2.79)

45 per 1009 implants

53 per 1000 implants

Very lowa,d,e

Difference: 8 more per 1000 patients (23 fewer to 81 more)

8 years

121 (1 RCT)

RR 1.69 (0.42 to 6.78)

49 per 1000 implants

83 more per 1000 implants

Very lowa,d,e

Difference: 34 more per 1000 patients (29 fewer to 284 more)

 Marginal bone loss (change from baseline)

1 year

209 (4 RCTs, 1 NRSI)

The mean MBL ranged from 0.75 to 1.25 mm

MD 0.07 mm lower (0.14 lower to 0.01 higher)

Very lowa,b,c,e,g

3 years

142 (4 RCTs)

The mean MBL ranged from 1.39 to 1.76 mm

MD 0.32 mm lower (0.44 lower to 0.19 lower)

Lowa,f

5 years

Short dental implant length of 4 to < 6 mm

44 (2 RCTs)

-

The mean MBL ranged from 1.7 to 2.1 mm

MD 0.45 mm lower (0.72 lower to 0.18 lower)

Lowa,f

Short dental implant length of 6 to 8.5 mm

119 (2 RCTs, 1 NRSI)

The mean MBL ranged from 1.61 to 2.34 mm

MD 0.84 mm lower (1.07 lower to 0.61 lower)

Lowa,f

8 years

Short dental implant length of 6 to 8.5 mm

47 (1 RCT)

The mean MBL was 2.46 mm

MD 0.88 mm lower (1.26 lower to 0.5 lower)

Lowa,f

 Biological complications (before and after loading)

1 year

Short dental implant length of 4 to < 6 mm

119 (2 RCTs)

RR 0.48 (0.25 to 0.93)

295 per 1000 implants

142 per 1000 implants

Very lowa,d,e

Difference: 153 fewer per 1000 implants (221 fewer to 21 fewer)

Short dental implant length of 6 to 8.5 mm

379 (3 RCTs)

RR 0.12 (0.04 to 0.32)

188 per 1000 implants

23 per 1000 implants

Moderatea

Difference: 165 fewer per 1000 implants (180 fewer to 128 fewer)

3 years

Short dental implant length of 4 to < 6 mm

119 (2 RCTs)

RR 0.66 (0.39 to 1.09)

475 per 1000 implants

314 per 1000 implants

Very lowa,d,e

Difference: 161 fewer per 1000 patients (290 fewer to 43 more)

Short dental implant length of 6 to 8.5 mm

209 (2 RCTs)

RR 0.21 (0.10 to 0.46)

324 per 1000 implants

68 per 1000 implants

Moderatea

Difference: 256 fewer per 1000 implants (292 fewer to 175 fewer)

5 years

Short dental implant length of 4 to < 6 mm

119 (2 RCTs)

RR 0.77 (0.42 to 1.42)

475 per 1000 implants

366 per 1000 implants

Very lowa,d,e

Difference: 109 fewer per 1000 implants (276 fewer to 200 more)

Short dental implant length of 6 to 8.5 mm

306 (2 RCTs, 1 NRSI)

RR 0.22 (0.12 to 0.40)

346 per 1000 implants

76 per 1000 implants

Moderatea

Difference: 270 fewer per 1000 implants (304 fewer to 208 fewer)

8 years

Short dental implant length of 6 to 8.5 mm

121 (1 RCT)

RR 0.34 (0.17 to 0.66)

443 per 1000 implants

151 per 1000 implants

Moderatea

Difference: 292 fewer per 1000 implants (367 fewer to 150 fewer)

Prosthetic level

 Prosthesis failures and complications

3 years

154 (4 RCTs)

RR 0.65 (0.23 to 1.84)

117 per 1000 implants

76 per 1000 implants

Very lowa,d,e

Difference: 41 fewer per 1000 patients (90 fewer to 98 more)

5 years

176 (4 RCTs, 1 NRSI)

RR 0.91 (0.45 to 1.84)

161 per 1000 implants

147 per 1000 implants

Very lowa,d,e

Difference: 14 fewer per 1000 patients (89 fewer to 135 more)

8 years

48 (1 RCT)

RR 1.23 (0.31 to 4.90)

130 per 1000 implants

160 per 1000 implants

Very lowa,d,e

Difference: 30 more per 1000 patients (90 fewer to 509 more)

Patient satisfaction

 Patient’s treatment preference side (split-mouth)

1-month post-loading

40 (1 RCT)

One month after delivery of the definitive prostheses, an independent assessor asked the patients which treatment they preferred. All 20 patients treated with mandibular implants preferred short implants side vs conventional length implants placed in augmented bone side (p < 0.0001)

Lowa,e

Cost-effectiveness

There is no data regarding the costs, or other economic evaluation that assess the focused question of the present umbrella review

  1. Patient or population: atrophic mandible
  2. Setting: private dental clinic—Italy
  3. Intervention: short dental implants in native bone
  4. Comparison: regular dental implants and bone augmentation
  5. GRADE Working Group grades of evidence—high certainty: we are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
  6. CI confidence interval, MD mean difference, NRSI non-randomized study of intervention, RCT randomized controlled trial, RR risk ratio
  7. Explanations
  8. Risk of bias: aHigh risk of bias studies largely contribute to the weighted overall estimate of effect due to the lack of blinding of participants, surgeons and evaluators. We decided to downgrade only one level, as we recognized the impossibility to blind the intervention and comparison (evident differences between implant lengths). In addition, we did not downgrade due to the lack of sample size calculations (high risk of other bias), as we could perform a post-hoc power analysis for the meta-analysis using TSA
  9. Inconsistency: bSensitivity analysis: the source of heterogeneity may be due to the differences of the risk of bias between Pieri 2017 (moderate risk of bias) and the other RCTs (high risk of bias). We decided to downgrade one level because of this. cThere is a statistically significant moderate to high heterogeneity (assessed with I2 and p value). Therefore, we decided to downgrade one level
  10. Indirectness: we do not have serious concerns regarding the indirect evidence or clinical diversity of the included studies (PICO)
  11. Imprecision: dWide confidence intervals that include “no effect” and appreciable benefits and harms (RR less than 0.75 or over 1.25). Therefore, we decided to downgrade two levels. eThe available number of events does not allow to reach the calculated Optimal Information Size. Therefore, we decided to downgrade one level. fAlthough the OIS is reached by power calculations, and in consequence, is sufficient to detect statistically significant differences, we decided to downgrade one level because there is not a minimal important difference reported in the literature that allows an adequate clinical difference estimate. gWide confidence intervals that include “no effect” and appreciable benefits and harms (minimal clinical difference set to “MD different from zero”). Therefore, we decided to downgrade one level
  12. Publication bias: we do not have serious concerns regarding the publication bias (funnel plot observation)
  13. *Participants or implants
  14. **The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI)